BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27085747)

  • 1. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for prostate cancer.
    Croswell J; Shin YR
    Am Fam Physician; 2013 Feb; 87(4):283-4. PubMed ID: 23418805
    [No Abstract]   [Full Text] [Related]  

  • 4. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: Prudent practice optimizes screening outcomes.
    Auvinen A
    Nat Rev Urol; 2016 Jul; 13(7):376-7. PubMed ID: 27215425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations against prostate cancer screening with PSA].
    Marzo-Castillejo M; Nuin-Villanueva MÁ; Vela-Vallespín C
    Aten Primaria; 2012 Jul; 44(7):377-8. PubMed ID: 22520080
    [No Abstract]   [Full Text] [Related]  

  • 8. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"?
    Barry MJ; Albertsen PC
    Ann Intern Med; 2016 May; 164(10):687-8. PubMed ID: 26902323
    [No Abstract]   [Full Text] [Related]  

  • 9. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
    Pinsky PF; Prorok PC; Kramer BS
    N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509
    [No Abstract]   [Full Text] [Related]  

  • 12. First, do no harm.
    Pimlott N
    Can Fam Physician; 2012 Sep; 58(9):915. PubMed ID: 22972717
    [No Abstract]   [Full Text] [Related]  

  • 13. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction.
    Carroll PR
    JAMA Surg; 2018 Aug; 153(8):701-702. PubMed ID: 29801146
    [No Abstract]   [Full Text] [Related]  

  • 14. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 15. 2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.
    Prasad SM; Drazer MW; Huo D; Hu JC; Eggener SE
    JAMA; 2012 Apr; 307(16):1692-4. PubMed ID: 22535850
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate-specific antigen screening, why have the guidelines changed?
    Sountoulides P; Moutzouris G
    Expert Rev Anticancer Ther; 2014 Nov; 14(11):1277-81. PubMed ID: 25306859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
    Borofsky MS; Makarov DV
    Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 20. Reevaluating PSA Testing Rates in the PLCO Trial.
    Shoag JE; Mittal S; Hu JC
    N Engl J Med; 2016 May; 374(18):1795-6. PubMed ID: 27144870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.